Chapter 792: Become the boss lady and send her off personally (Part 1)
There are three tablets of this kind. Take one with a glass of water, then add the small tablet and drink another glass of water.
So, Jiang Fuyue drank four glasses of water in total.
After finally swallowing it, I started to feel nauseous again.
Xie Dingyuan patiently stroked her back with his palm over and over again, from top to bottom.
"Are you feeling better?"
Jiang Fuyue's eyes turned red and she shook her head when she heard that.
It took five minutes before I recovered.
"Which company makes this pill? It's so inhumane. How can anyone swallow it when it's so huge?"
Xie Dingyuan coughed lightly: "...History."
"?"
"It was developed and manufactured by Historical Biology and then exported to Continent F."
Jiang Fuyue: “…” Is it okay to complain to the person who caused the trouble?
"When you become the boss lady of history, the product department will be on standby at your command, no matter how small the change is."
When the man said this, his expression was serious, without any intention of joking.
Jiang Fuyue: “…” That’s not necessary.
"Want some more water?"
Jiang Fuyue: "Half a cup."
Xie Dingyuan took a glass, let her drink it first, and drank the rest in one gulp.
"I want the relevant experimental data and clinical reports of the recombinant vaccine. Would you be willing to provide them?" She did not forget the purpose of this trip.
The man raised an eyebrow: "What do you want these for?"
"Improve the defense capabilities of existing vaccines. I saw a news report saying that the current effectiveness is only 50%?"
Xie Dingyuan shook his head. "It's actually even lower. Judging from the clinical trial results, it's only 43% so far."
Not even fifty yet.
Jiang Fuyue: "I've calculated using a model that in order to establish an immune barrier, the vaccination rate in North F Africa should reach at least 70%. But this number assumes that the vaccine's efficacy is above 50%."
"Based on the current situation, the vaccination rate may need to be higher."
Xie Dingyuan: "But in the final analysis, the recombinant vaccine's efficacy is too low. I tried to study adenovirus vector vaccines, but the experimental results were not satisfactory."
Jiang Fuyue: "What do you mean?"
"It has high safety, but insufficient effectiveness, and it is difficult to overcome 'pre-existing immunity'."
Jiang Fuyue pondered for a moment: "Have you considered an attenuated influenza virus vector vaccine?"
Xie Dingyuan paused. "Are you saying that we can use an approved attenuated influenza virus vaccine as a vector, carrying the M protein of the Shenkewo virus, to stimulate the body to produce antibodies against both viruses?"
"Yes, especially when the Shenkewo infection overlaps with the peak influenza season, the clinical significance will be very significant. It is equivalent to preventing two diseases with one vaccine, with fewer vaccinations and a relatively simple vaccination method..."
This discussion lasted for two hours in a blink of an eye.
Xie Dingyuan sorted out the relevant information and clinical reports and handed them to Jiang Fuyue.
“…That’s about it.”
"Okay." Jiang Fuyue nodded and put the things into the bag.
Xie Dingyuan: "The most researched areas here are inactivated vaccines and protein recombinant vaccines. The adenovirus vector vaccine is being researched by Bai Chuanhao's team and they are also here this time. The progress should not be too slow."
He was reminding her.
If it is really decided to focus the next research on live attenuated vaccines, Jiang Fuyue must hurry up.
So far, no team in the world has successfully developed this vaccine.
There are even few relevant papers.
Because, its research and development difficulty is proportional to its significant advantages.
The common live attenuated vaccines currently on the market include live attenuated Japanese encephalitis vaccine, live attenuated hepatitis A vaccine, live attenuated measles vaccine, etc.
All of these have gone through a long research and development process before they were finally released to the market.
Xie Dingyuan: "You need to think clearly: should we improve the effectiveness of the existing protein recombinant vaccine, or should we start from scratch and research a live attenuated vaccine?"
Although the former is not easy, at least there is still hope. The latter... can only be said to be a gamble.
If you win, you will be in great glory.
If you lose, you gain nothing.
After hearing this, Jiang Fuyue was silent for a moment.
After a while, he spoke again: "I will think about it carefully."
Xie Dingyuan nodded: "If you need anything, use the intercom to contact me."
Speaking of walkie-talkies…
Jiang Fuyue: "I don't know your channel number yet."
"29.1 Hz."
…
Jiang Fuyue took the information and prepared to go back next door, and Xie Dingyuan sent her out.
"Think carefully about what I said and make a decision quickly."
"good."
"Remember to take your medicine tomorrow. Forget it, just come over and take it. I have it all ready here anyway."
Jiang Fuyue: “…” No, I won’t come.
"Then I'll go back first."
The man nodded and watched her leave until she disappeared, then he turned around and went back.
Wherever he went, he caused surprise—
"The professor didn't get angry? And he even came out to see them off in person?"
"Did I get the right script? Or did I go to the wrong set?"
"Am I the only one who saw that curve of what looked like a smile on the professor's lips?"
"To be honest, I saw it too."
"So what's the situation now?"
Everyone looked at each other, a little confused.
Xie Dingyuan had already passed the crowd, bringing a gust of cool breeze. Suddenly, he paused, turned around, and glanced at the team members.
Everyone: “!” Level 1 alert!
One update, two thousand.
(End of this chapter)
Continue read on readnovelmtl.com